文献速递消化、代谢与肾脏急症心脑血管急症

基于时间与基于步数的身体活动指标与健康的关系

Time- vs Step-Based Physical Activity Metrics for Health.
PubMed 文献 · JAMA Intern Med · 2024-01-01
一句话结论在62岁及以上女性中,中高强度身体活动(MVPA)时间与步数均与全因死亡和心血管病风险降低相关,且两者关联程度相似,作者认为未来指南应考虑步数目标。

该队列研究分析了妇女健康研究随访中62岁及以上、无心血管病和癌症的女性参与者,用加速度计连续7天测量MVPA时间和步数。中位随访9.0年,每增加1个标准差,MVPA时间与全因死亡的HR为0.82(95%CI 0.75-0.90),步数为0.74(95%CI 0.69-0.80);两者与无死亡生存期延长相关(分别延长2.22个月和2.36个月),AUC均为0.55(95%CI 0.52-0.57),与心血管病的关联也相似。作者认为步数目标可与时间目标一起纳入未来指南,以兼顾个人偏好。

要点

  • 在62岁及以上女性中,每增加1个标准差,MVPA时间与全因死亡的HR为0.82(95%CI 0.75-0.90),步数为0.74(95%CI 0.69-0.80)。
  • MVPA时间和步数处于上3个四分位组相比最低四分位组,9年随访时无死亡生存期分别延长2.22个月(95%CI 1.58-2.85)和2.36个月(95%CI 1.73-2.99)。
  • MVPA时间与步数对全因死亡的AUC均为0.55(95%CI 0.52-0.57),两者判别能力相似。
  • 上述两种指标与心血管病(心肌梗死、卒中和心血管病死亡的复合终点)的关联也相似。
  • 作者认为,未来指南在制定基于时间的目标时,应考虑纳入基于步数的目标,以兼顾个人偏好。

适用人群与场景

  • 美国妇女健康研究随访中62岁及以上、无心血管病和癌症、完成年度问卷并同意用加速度计测量身体活动的女性参与者,随访至2022年12月31日。

研究设计与关键结果

  • 研究类型为队列研究,分析妇女健康研究(1992至2004年在美国开展的随机临床试验,评估低剂量阿司匹林和维生素E预防癌症和心血管病)存活参与者的 ongoing 随访数据,纳入14 399名女性,平均(SD)年龄71.8(5.6)岁。
  • 加速度计连续7天测量MVPA时间和步数,中位(IQR)MVPA时间为每周62(20-149)分钟,步数为每日5183(3691-7001)步。
  • 中位(IQR)随访9.0(8.0-9.9)年,每增加1个标准差,全因死亡的HR:MVPA时间0.82(95%CI 0.75-0.90),步数0.74(95%CI 0.69-0.80)。
  • MVPA时间和步数处于上3个四分位组相比最低四分位组,9年随访时无死亡生存期分别延长2.22个月(95%CI 1.58-2.85)和2.36个月(95%CI 1.73-2.99)。
  • MVPA时间和步数对全因死亡的AUC均为0.55(95%CI 0.52-0.57)。
  • 上述两种指标与心血管病(心肌梗死、卒中和心血管病死亡的复合终点)的关联也相似。

证据类型、等级与局限

  • 证据类型:队列研究(对随机临床试验存活参与者的随访研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在62岁及以上女性中,MVPA时间和步数与全因死亡和心血管病的关联在性质上相似,未来指南在制定基于时间的目标时,应考虑纳入基于步数的目标,以兼顾个人偏好。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Current US physical activity (PA) guidelines prescribe moderate to vigorous PA (MVPA) time of at least 150 minutes per week for health. An analogous step-based recommendation has not been issued due to insufficient evidence.

OBJECTIVE: To examine the associations of MVPA time and step counts with all-cause mortality and cardiovascular disease (CVD).

DESIGN, SETTING, AND PARTICIPANTS: This cohort study analyzed data from an ongoing follow-up study of surviving participants of the Women's Health Study, a randomized clinical trial conducted from 1992 to 2004 in the US to evaluate use of low-dose aspirin and vitamin E for preventing cancer and CVD. Participants were 62 years or older who were free from CVD and cancer, completed annual questionnaires, and agreed to measure their PA with an accelerometer as part of a 2011-2015 ancillary study. Participants were followed up through December 31, 2022.

EXPOSURES: Time spent in MVPA and step counts, measured with an accelerometer for 7 consecutive days.

MAIN OUTCOMES AND MEASURES: The associations of MVPA time and step counts with all-cause mortality and CVD (composite of myocardial infarction, stroke, and CVD mortality) adjusted for confounders. Cox proportional hazards regression models, restricted mean survival time differences, and area under the receiver operating characteristic curve (AUC) were used to evaluate the associations.

RESULTS: A total of 14 399 women (mean [SD] age, 71.8 [5.6] years) were included. The median (IQR) MVPA time and step counts were 62 (20-149) minutes per week and 5183 (3691-7001) steps per day, respectively. During a median (IQR) follow-up of 9.0 (8.0-9.9) years, the hazard ratios (HR) per SD for all-cause mortality were 0.82 (95% CI, 0.75-0.90) for MVPA time and 0.74 (95% CI, 0.69-0.80) for step counts. Greater MVPA time and step counts (top 3 quartiles vs bottom quartile) were associated with a longer period free from death: 2.22 (95% CI, 1.58-2.85) months and 2.36 (95% CI, 1.73-2.99) months at 9 years follow-up, respectively. The AUCs for all-cause mortality from MVPA time and step counts were similar: 0.55 (95% CI, 0.52-0.57) for both metrics. Similar associations of these 2 metrics with CVD were observed.

CONCLUSION AND RELEVANCE: Results of this study suggest that among females 62 years or older, MVPA time and step counts were qualitatively similar in their associations with all-cause mortality and CVD. Step count-based goals should be considered for future guidelines along with time-based goals, allowing for the accommodation of personal preferences.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Hamaya R, Shiroma EJ, Moore CC, et al. Time- vs Step-Based Physical Activity Metrics for Health. JAMA Intern Med. 2024. PMID: 38767892. doi:10.1001/jamainternmed.2024.0892

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。